() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Tilray Inc.

Tilray® Boosts International Export Capacity with Manufacturing License and GMP Certification at EU Campus

May 23, 2019 Tilray, Inc. (“Tilray” or “the Company”) (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced that its wholly-owned subsidiary Tilray Portugal Unipessoal Lda. (“Tilray Portugal”) has received a standard manufacturing license and a Good Manufacturing Practices (GMP) certification, in accordance with the European Medicines Agency’s (EMA) standards, for its Biocant Park manufacturing facility in Cantanhede, Portugal.
Read more

Tilray, Inc. Reports Full Year 2018 Financial Results

Tilray, Inc., (“Tilray” or the “Company”) (Nasdaq: TLRY) a global leader in cannabis research, cultivation, production and distribution, today reported financial results for the fourth quarter and year ended December 31, 2018. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.
Read more

LiveWell Finalizes Hemp CBD Supply Agreement with Tilray

LiveWell Canada Inc. ("LiveWell" or the “Company"), (CSE: LVWL), today announced it has finalized its CBD supply agreement with Tilray Inc. (NASDAQ: TLRY). LiveWell will supply Tilray with a monthly quantity of up to 300 kilograms of hemp-derived CBD isolate, or an equivalent amount of full-spectrum CBD extract. The Company expects to begin shipping Tilray its product during the second quarter of 2019.
Read more